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Available online 18 September 2013Abstract Methods for the isolation of live neural stem cells from the brain are limited due to the lack of well-defined cell
surface markers and tools to detect intracellular markers. To date most methods depend on the labeling of extracellular
markers using antibodies, with intracellular markers remaining inaccessible in live cells. Using a novel intracellular protein
FABP7 (Fatty Acid Binding Protein-7) selective fluorescent chemical probe CDr3, we have successfully isolated high FABP7
expressing cells from the embryonic and adult mouse brains. These cells are capable of forming neurospheres in culture,
express neural stem cell marker genes and differentiate into neurons, astrocytes and oligodendrocytes. Characterization of
cells sorted with Aldefluor or antibodies against CD133 or SSEA-1 showed that the cells isolated by CDr3 exhibit a phenotype
distinct from the cells sorted with conventional methods. FABP7 labeling with CDr3 represents a novel method for rapid
isolation of neural stem cells based on the expression of a single intracellular marker.
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http://dx.doi.org/10.1016/j.scr.2013.09.002multiple types of neuron and glia. They form free floating
spheres if cultured in a medium containing growth factors
(Fischer et al., 2011). These properties make them much
coveted tools in the field of regenerative medicine where it is
hoped that they can be utilized to regenerate neurons that have
been lost as a result of disease or injury (Ruff and Fehlings,
2010). NSCs aremost abundant in the developing fetal brain and
persist throughout the whole life generating new neurons and
glia continuously. The study of NSCs from adult brain tissue is
particularly challenging because the cells are low in number
(0.1–1%) and require specialized and tedious cell preparation
techniques which have limited yield (Brewer and Torricelli,
2007; Galli et al., 2003). As such, considerable research has
1315Neural stem cell isolation from the whole mouse brain using FABP7-binding fluorescent dye, CDr3been focused on developing isolation techniques for these
elusive cells.
Major obstacles to isolate NSCs have been the lack of NSC
specific cell surface markers and tools to detect intracellular
markers which are more specific both in the developing and
mature brain. Commonly used methods of NSC labeling either
involve antibody for cell surface marker labeling or fluorescent
protein expression with the desired marker of interest (Fischer
et al., 2011; Corti et al., 2007; Coskun et al., 2008). Presently,
the most widely used cell surface markers for the isolation of
NSCs are CD133 and SSEA-1 (Capela and Temple, 2002; Corti et
al., 2007). The fluorescent dye, AldeFluor which is catalyzed by
the intracellular metabolic enzyme aldehyde dehydrogenase to
be retained in the cell has also been demonstrated to enrich for
NSCs (Corti et al., 2006). More recently, the stem cell specific
fluorescent dye CDy1, developed by us as a pluripotent stem
cell probe (Im et al., 2010) has also been shown to be able to
isolate NSC from the mouse brain although the mechanism of
action remains to be elucidated (Vukovic et al., 2013). Using a
combination of the three NSC markers (CD133, SSEA-1 and
AldeFluor), Obermair et al. reported several subpopulations of
neural stem/progenitors within the brain (Obermair et al.,
2010). Fischer et al. reported the isolation of NSCs from
GFAP+/CD133+ cells from the adultmouse brain (Fischer et al.,
2011). On the other hand, other studies have shown that the
expression of CD133 in NSC depends on developmental stage
(Pfenninger et al., 2007) and that a significant portion of NSC
does not express this marker (Sun et al., 2009).
Brain cell preparation necessitates the use of enzymatic
dissociation to mitigate the otherwise damaging effects of
mechanic dissociation, with trypsin and papain being the two
most commonly used agents (Oliver-De la Cruz and Ayuso-
Sacido, 2012). Inconsistent findings in multiple independent
studies might have been attributed to cell surface antigen
cleavage during enzymatic dissociation of brain tissue
(Panchision et al., 2007). Efforts have been made to minimize
antigen cleavage by developing milder enzymatic treatment
agents. However their effectiveness is subject to the antigen
of interest and it is still difficult to eliminate the possibility of
antigen cleavage completely. Isolation of live NSC by labeling
intracellular markers with antibodies is not possible, because it
requires membrane permeabilization which kills the cells thus
making it unfeasible for self renewal and other live cell assays
downstreamof labeling. Fluorescent protein co-expressionwith
an intracellular marker requires tedious methods to generate
transgenic mice and must be approached with caution since
genetic modification may affect the native cellular physiology.
Therefore, direct labeling of a specific intracellular marker
would provide a means of simple and effective isolation of NSC
for downstream applications.
In a previous study we presented a small molecule fluo-
rescent probe, compound of designation red 3 (CDr3), which
binds specifically to FABP7 in NSCs of both human and mouse
origin (Yun et al., 2012). Due to its low molecular weight
(Mr = 572) and high lipophilicity (cLogP = 8), CDr3 is capable of
diffusing passively through the cellmembrane and is retained by
FABP7-expressing NSCs leading to selective staining. FABP7 is
expressed ubiquitously in developing radial glia in the central
nervous system, with different subpopulations of progenitor
cells restricted to individual fates (Schmid et al., 2006). At late
embryonic and post-natal stages, a subpopulation of these
radial glia gives rise to NSCs that are implicated in adultneurogenesis (Malatesta et al., 2008). NSCs express high levels
of FABP7. However, its expression level drops significantly by
differentiation of NSCs. (Conti et al., 2005; Arai et al., 2005).
Studies have also shown that NSC numbers are dramatically
reduced in FABP7 knockout mouse models (Matsumata et al.,
2012). This strongly suggests that FABP7 plays a critical
functional role in neurogenesis and regeneration (Matsumata
et al., 2012). Both the embryonic and adult mouse brains are
known to contain populations of cells that express varying levels
of FABP7 (Gerstner et al., 2008). Here we demonstrate that
CDr3 can be used to isolate high FABP7 expressing live cells from
the embryonic and adult mouse brains which share character-
istics with knownNSCmarkers. CDr3 can be reliably used for the
easy and rapid isolation of NSCs from complex brain tissues.
Materials and methods
Brain cell preparation
For the preparation of cells from the embryonic and adult
mouse brains, E14 embryos and brains from 8–12 week old
adults were used. For embryos, the whole embryo brain was
dissected out and digested in 0.25% trypsin–EDTA (GIBCO) for
15 min at 37 °C. To achieve a single cell suspension, the trypsin
was neutralized with FBS and the brains were resuspended in
PBS before sequential trituration using pipettes of decreasing
diameter. Cell suspensions were washed three times with PBS
before filtering through a 40 μm strainer. For the adult brain,
whole brain without cerebellum was dissected and minced in
20 U/mg of papain solution (Worthington) for 1 h at 37 °C
before trituration and washing as described above. Animals
were prepared and sacrificed in accordance with the protocol
approved by the Institutional Animal Care and Use Committee.
Cell sorting and flow cytometry
Embryonic and adult brain cells were stained for 1 h with
500 nM of CDr3 in neurosphere growth media consisting of
DMEM/F12, B27 without vitamin A, bFGF (10 ng/ml) and EGF
(20 ng/ml) (GIBCO), and penicillin–streptomycin glutamine
before sorting using the MoFlo XDP (Beckman Coulter). For
AldeFluor staining, we used the AldeFluor™ kit (STEMCELL
Technologies) according to the manufacturer's instructions.
Labeled single cell suspensions were pre-gated for size and
granularity before sorting based on their relevant fluorescence
marker. For immunostaining and sorting, cells were stained
with CD133 (Biolegend, 1:250) and SSEA-1 (Millipore, 1:250)
antibodies for 1 h followed by secondary antibody conjugated
to Alexa Fluor 488 (Life Technologies). For flow cytometry
analysis, the primary antibodies against CD133 (Biolegend),
SSEA-1 (Millipore), FABP7 (Abcam), and ALDH1A1 (Santa Cruz)
were diluted 1:500 to stain. Flow cytometry analysis was
carried out on a BD LSRII analyzer. All sorting experiments
were carried out n = 3–5 times with the data shown reflecting
the data from one representative independent experiment.
Neurosphere assay and differentiation
Embryo and adult derived neurospheres were grown in DMEM/
F12 supplemented with B27 without vitamin A, 20 ng/ml of
EGF, 10 ng/ml of bFGF and penicillin–streptomycin glutamine
1316 C. Leong et al.and cultured for 4–7 days depending on the experimental
conditions. For neurosphere assay cell sorting, a total of
10,000 cells were plated per well of a six well plate in
triplicate. To assess differentiation capacity, neurospheres
were differentiated on poly-D-lysine (Sigma) coated plates for
5 days in DMEM/F12 + 10% FBS (GIBCO) before fixation in 4%
paraformaldehyde. To determine self-renewal for secondary,
tertiary and further assays, primary assay neurospheres were
pooled and triturated to a single cell suspension in 0.05 M
NaOH followed by neutralization with 0.05 M HCl. The cells
were then re-plated at a density of 1000–2000 cells per well in
fresh neurosphere growth media.
MTS assay
For the measurement of cell proliferation by MTS assay
(Promega), 100,000 cells were sorted with their respective
markers (whole, CDr3, AldeFluor, CD133 or SSEA-1) and re-
cultured for 5–6 days to form neurospheres. Spheres were
subsequently dissociated using 0.05 M NaOH treatment and
plated in entirety in triplicate on a 96 well plate. The addition
of 20 μl of MTS reagent was added to the cell solution and the
readings were measured at 490 nm after 4 hour incubation.
Cell immunostaining
For triple immunostaining of neurons, astrocytes and oligo-
dendrocytes from differentiated neurospheres, cells fixed with
4% paraformaldehyde were first blocked in 1% BSA followed by
O4 antibody staining (Millipore, 1:1000) and secondary antibody
staining (AlexaFluor 488, Life technologies). This was followed
by permeabilization with 0.1% Triton-X and antibody staining
with β-III-tubulin (Sigma) and GFAP (Wako) at 1:500–1:1000
dilutions. For further secondary antibody staining, AlexaFluor
546 and Cy5 conjugated antibodies (Life Technologies) were
used respectively at dilution factors of 1:100. Images were
acquired on the Nikon Ti microscope.
Gene expression analysis
For the analysis of gene expression, RNA was extracted from
whole, bright and dim FACS sorted cells using the QIAGEN
RNeasy purification kit according to the manufacturer's
instructions. RNA samples were analyzed by qRT-PCR with
the SYBR Green Master mix reagents (Applied Biosystems)
with normalization to GAPDH expression. The full list of
primers and their respective efficiencies can be viewed in
the Supplementary Materials and Methods.
Results
CDr3 can be used to isolate FABP7-positive cells
from the embryonic and adult mouse brains
FABP7 is expressed in a large population of cells in the
developing embryo brain but only constitutes about 1% of
the brain cell population by adult hood (Brewer and
Torricelli, 2007). CDr3 (Fig. 1a) staining could be visualized
in culture where certain cells in neurospheres and dissociated
brain cells appeared much more brightly stained than theirsurrounding cells (Fig. 1b). When applied to mixtures of
primary embryonic and adult mouse brain cell preparations,
CDr3 was sufficiently specific for the clear identification of a
distinct population of primary brain cells (Supplementary
Fig. 1). As such we were interested to determine if high FABP7
expression alone (as gated by the brightest 10% of CDr3
positive cells — Supplementary Fig. 1) was sufficient for the
isolation and characterization of NSCs from the brain.
High FABP7 expressing cells form neurospheres
For the assessment of self-renewal capacity, the brightest
and dimmest 10% of the CDr3 positive cell populations from
E14 embryonic mouse brains were sorted out and plated for
neurosphere assay. CDr3Bright cells were highly proliferative
compared to their CDr3Dim counterparts, which hardly
formed spheres (Fig. 1c).
When compared to the unsorted (whole) fraction, CDr3 NSC
enrichment resulted in an up to 5 fold increase in neurosphere
yield which was comparable to the established methods of
neurosphere enrichment by cell sorting using AldeFluor or
antibodies against CD133 and SSEA-1 in number (Fig. 1c) and
size (Fig. 1d) of neurospheres when applied to embryonic
mouse brain cells. Because neurospheres themselves cannot
be considered clonal entities (Singec et al., 2006), an MTS assay
was also carried out to measure the proliferative activity of the
isolated cells (Fig. 1e). All marker sorted cells were significantly
more proliferative compared to the whole sorted fraction.
High capacity for self-renewal is characteristic of NSCs as
opposed to neural progenitors, which lose their self-renewal
capacity after several passages. CDr3 sorted NSCs from
embryonic and adult brain were successfully serial passaged
at a yield that was higher than that of neurospheres generated
from unsorted cells (Supplementary Figs. 2a and b). A
comparison of neurospheres grown in 500 nM of CDr3 and
0.1% DMSO containing media showed that the dye does not
affect the ability of the cells to form spheres (Supplemen-
tary Figs. 2c and d).
CDr3 enriches for NSCs in the adult brain
Adult NSCs are far fewer and have more restricted growth
conditions as compared to embryo derived cells (Morshead
and van der Kooy, 2004). In adult brain cell preparation,
there is also a considerable amount of myelin and cell debris
which makes cell isolation difficult (Fig. 2a). The subven-
tricular zone (SVZ) of the adult brain is known to harbor the
highest percentage of NSCs and is thus usually the region of
choice when isolating adult NSCs to reduce complexity of the
tissue. We compared the number of primary neurospheres
generated from a whole hemisphere versus the dissected
SVZ region of the other hemisphere from the same brain. Our
data showed that the SVZ accounts for up to 50% of the
neurospheres formed from one hemisphere of the brain.
However, a significant portion of neurospheres can also be
derived from the remaining regions of the brain. Thus by
dissecting only the SVZ, up to 50% of neurosphere yield from
the brain is lost which is considerable given the relative scarcity
of NSCs in the adult brain. CDr3 enrichment provided a much
cleaner cell preparation of adult brain derived neurospheres
which were bigger and could be used for further experiments
Figure 1 (a) Structure of the Fabp7 selective fluorescent dye, CDr3. (b) Confocal microscope images of CDr3 stained neurosphere and
embryo brain primary cells. The yellow arrow indicates CDr3Bright cells. Scale bar, 20 μm. (c) Number of neurospheres generated from
unsorted (whole) and sorted embryo brain cells by CDr3, AldeFluor, CD133 antibody and SSEA-1 antibody. The sortingwas carried out n = 5
times with the data reflecting the best yield from one independent experiment. An unpaired two tailed t test was performed (whole vs.
bright, **p b 0.01). (d) Size of neurospheres generated from sorted embryo brain cells by CDr3, Aldefluor, CD133 antibody and SSEA-1
antibody. (e) An MTS assay was performed on cells dissociated from unsorted (whole), CDr3, AldeFluor, CD133 and SSEA-1 sorted
neurospheres. An unpaired, two tailed t test was performed (whole vs. sorted, *p b 0.05, **p b 0.01). Values shown representmean ± S.D.
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higher levels of enrichment (Fig. 2c). Attempts to sort cells from
the whole adult brain by CD133 and SSEA-1 antibody sorting
failed to produce any spheres in culture.
CDr3 isolated neurospheres are multipotent
NSCs are capable of differentiating into all three neural cell
types i.e. neurons, astrocytes and oligodendrocytes, whereasFigure 2 (a) Neurospheres generated from unsorted and sorted cells i
of neurospheres generated from unsorted (whole) and sorted adult mous
**p b 0.01. (c) Number of neurospheres generated from unsorted (who
yielded a significantly higher number of neurospheres (**p b 0.01) compneural progenitors have a more restricted differentiation
lineage (Klein and Fishel, 2004). Upon differentiation of neu-
rosphere derived NSCs, FABP7 expression is decreased and
CDr3 staining is lost (Supplementary Fig. 3a). CDr3 isolated
neurospheres from both embryonic and adult brains could be
effectively differentiated into all three cell types (Fig. 3a),
with robust staining for their respective antibodymarkers. This
potential for multi-lineage differentiation validates their NSC
phenotype.solated from embryonic and adult brains. Scale bar, 20 μm. (b) Size
e brain cells by CDr3. A Mann–Whitney U test was performed where
le) and sorted adult mouse brain cells by CDr3 and Aldefluor. CDr3
ared to Aldefluor. Values shown represent mean ± S.D.
1318 C. Leong et al.To demonstrate that CDr3 does not affect the ability
of neural stem cells to differentiate into neurons which
would potentially impede neurogenesis, neurospheres were
dissociated into single cells and induced to neuronalFigure 3 (a) CDr3 sorted primary neurospheres from the E14 embry
β-III-tubulin (neurons), GFAP (astrocytes) and O4 (oligodendrocytes). Sc
in unsorted (whole) and sorted embryo and adult brain cells by CDr3. A
and **p b 0.01). Values shown represent mean ± S.D.differentiation in the presence and absence of CDr3. There
was no significant difference in the number of neurons
generated from DMSO and CDr3 treated cells (Supplemen-
tary Fig. 3b).onic and adult brains were differentiated and immunostained for
ale bar, 20 μm. (b) Expression of neural stem cell associated genes
n unpaired two tailed t test was performed for all genes (*p b 0.05
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In addition to FABP7, there are numerous other gene markers
that are known to be distinctively expressed in NSCs (Fischer
et al., 2011; Corti et al., 2006, 2007). For the gene expression
analysis, we used 8 different gene markers for the analysis of
the cell populations isolated from the embryonic and adult
brains. CDr3Bright cells were found to have higher expression of
FABP7 compared to CDr3Dim cells in both embryo and adult
sorted cells. This is consistent with the dye's FABP7 selectivity
(Fig. 3b). In addition, CDr3Bright cells also showed high ex-
pression of other known NSC markers such as Nestin, Hes1 and
Hes5. Pax6 expression was too low to be detected in the adult
brain. Comparison of unsorted (whole) versus CDr3Bright
samples also showed that CDr3 sorting significantly enriched
for high FABP7 expressing cells up to from 2–20 fold compared
to unsorted embryo derived brain cells (Fig. 3b). This confirms
that CDr3 is effective for use as a sorting tool for the isolation
of NSCs from the embryonic and adult brains.NSC phenotypes depend on isolation markers
Due to its intracellular localization, FABP7 is seldom used for
cell isolation. With the development of CDr3 as a live NSC
probe, we are now able to characterize these cells based on
their level of FABP7 expression alongside other cell surface
markers such as CD133 and SSEA-1. It is interesting to note
that while the fluorescent probe, AldeFluor, has been
successfully employed for the use of NSC isolation (Corti et
al., 2006), its representative binding target, ALDH1A1, is not
generally known to be a marker for NSCs. Moreover, recent
studies have shown that this protein may in fact be
dispensable for stem cell function (Levi et al., 2009).
To characterize the brain cells by their respective
phenotypes, cells derived from the whole E14 embryonic and
adult mouse brains were stained and sorted by CDr3, SSEA-1,
CD133 or AldeFluor. Live cells collected by sorting were then
co-labeled with another NSC marker (CDr3, AldeFluor, CD133
or SSEA-1) and analyzed by flow cytometry to determine the
percentage of cells expressing each NSC marker. It was
observed that marker profiles at E14 and adult stage were
distinct. CD133 and SSEA-1 occupied relatively selective
niches at E14 but their expressions expanded to encompass a
greater proportion of other cells by adult stage (Fig. 4a,
Supplementary Table 1). Although CDr3 was not the most
restricted lineage at E14 stage, expression area was markedly
reduced in the adult, especially in the proportion of CD133
positive cells. This is consistent with published literature and
our own results (Supplementary Fig. 4) which demonstrate
that CD133 expression is decreased in the adult versus embryo
stage. This suggests that CD133 may no longer be a strong NSC
marker in the adult mouse brain. AldeFluor appeared to be the
widest marker, with little change from E14 to adult (Fig. 4a,
Supplementary Fig. 4). This suggests that while it is capable of
isolating NSCs, it may not be a specific NSC marker.
Embryonic brain cells were also sorted using AldeFluor or
CD133 antibody and analyzed for FABP7 and ALDH1A1 gene
expression. While both AldeFluor and CD133 positive cells in
the embryo brain expressed high levels of FABP7, CD133
positive cells were found to express lower levels of ALDH1A1
than negative cells (Supplementary Figs. 5a and b). For livesorted cells, CDr3Bright cells showed high CD133 expression
(Fig. 4a) but low AldeFluor staining (Fig. 4b). An analysis of
CDr3Bright embryo brain cells immunostained with ALDH1A1
antibody showed that ALDH1A1 positive cells only constitute
about 10–20% of CDr3 bright sorted cells (Fig. 4c).
To further assess the importance of each marker in
conjunction with one another, subpopulations of cells were
sorted from E14 brains and assessed for neurosphere forming
capacity. SSEA-1+/AldeFluor− cells formed the largest number
of spheres (150 spheres), SSEA-1+/CD133− cells formed few
spheres (37 spheres) (Supplementary Table 2). This underscores
the importance of both CD133 and SSEA-1 as NSCmarkers in the
developing brain. However attempts to sort cells based on
CD133+ or SSEA-1+ alone did not produce the maximal number
of spheres (45 spheres from CD133+/SSEA-1−, 37 spheres from
SSEA-1+/CD133−). The inclusion of CDr3 as a sorting marker to
SSEA-1+ or CD133+ cells restored neurosphere yield (45 spheres
from CD133+/SSEA-1− to 114 spheres from CD133+/CDr3Bright,
37 spheres from SSEA-1+/CD133− to 94 spheres from SSEA-1+/
CDr3Bright). However the inclusion or exclusion of AldeFluor as a
sorting marker to SSEA-1+ and CD133+ did not appear to
influence sphere yield significantly. Including CD133 alongside
CDr3 improved the sphere yield by up to 10 times. These results
reflect the heterogeneity of NSCs.Discussion
While FABP7 has been shown to be expressed in NSCs, it has
not been used for live NSC isolation from a mixture of various
types of cells largely because of its intracellular nature
which necessitates cell permeabilization and hence cell
death in the process of detection using antibodies. In this
study, we demonstrated that the availability of CDr3 as an
intracellular live NSC probe now makes it possible to isolate
NSCs by the expression of FABP7.
To date, CD133 remains the most established NSC marker
for immunoseparation of NSCs from brain tissue (Fischer et al.,
2011; Corti et al., 2007). The importance of CD133 is
highlighted in the fact that almost all cells positive for other
markers show strong CD133 expression and that the inclusion or
exclusion of CD133 as a marker from CDr3 positive populations
strongly influences sphere yield. Our data has shown that
CD133 expression in the embryonic brain is generally high
(Fig. 4, Supplementary Fig. 4). But little CD133 expression was
detected in the adult brain which is in agreement with the data
reported by Pfenninger et al. (2007). Interestingly, the pro-
portion of CD133 expressing cells within the CDr3 population
fell from embryo to adult but expanded across other markers.
This represents a drawback of the use of CD133 as a NSCmarker
in the adult brain and suggests that its role as a NSC marker
differs depending on the age.
AldeFluor is a small molecule dye which has been shown
to be able to isolate NSCs from the brain (Corti et al., 2006).
Compared to CDr3, it requires more preparation such as dye
activation and blocking of the ABC transporter (Marcato et
al., 2011). Its binding target in stem cells has been shown to
be aldehyde dehydrogenase (ALDH1A1) (Storms et al., 1999).
However only 10% of high FABP7 expressing cells were
ALDH1A1 positive and its expression appeared to be broad
ranging in both the embryo and the adult. The higher
percentage of ALDH1A1 expressing cells in the dim fraction
Figure 4 (a) The percentage of marker sorted cells from embryo brain or adult brain expressing other markers measured by flow
cytometry. The live cells were co-labeled with CDr3, AldeFluor, CD133 antibody and SSEA-1 antibody and plotted on a radar plot to
illustrate the spread of marker expression when each population was limited to sorting by a particular marker as well as the respective
expression changes from embryo to adult. (b) The percentage of CDr3Bright cells co-labeled by AldeFluor, CD133 antibody and SSEA-1
antibody. (c) ALDH1A1 expressions in CDr3Bright cells were assessed by flow cytometry of immunostained cells.
1320 C. Leong et al.of CD133 sorted cells also suggests that that the ALDH1A1
positive population is underrepresented or absent in the CDr3
positive cell fraction and that the three markers (FABP7,
CD133 and ALDH1A1) may not be co-expressed in the major
population of NSCs. Neurosphere yields from AldeFluor sorted
adult brain cells were also lower than those from CDr3 sorting,
and the inclusion of Aldefluor as a subpopulation marker did
not affect neurosphere yield significantly. This suggests that
while some NSCs may express elevated levels of ALDH1A1, this
expression is not a critical marker of NSC property. This could
largely in part be due to the presence of alternative ALDH
isoforms present in mouse NSCs (Marcato et al., 2011).
It was also observed that the expression of Nestin, Hes1 and
Sox2 in CDr3Bright adult sorted cells were lower than the
unsorted fraction or largely unchanged. Studies have shown
that it is likely that multiple classes of neural stem/progenitor
cells exist, each classified by distinct gene expression profiles.A study by Hendrickson et al. (2011) has found that four distinct
classes of nestin expressing cells exist in the mature adult
brain, one of which consists of a class of terminally differen-
tiated neurons (Hendrickson et al., 2011). This suggests that
the expression of nestin alonemay not be a reliable indicator of
neural cell stemness in the adult brain andmay account for the
lack of nestin enrichment in CDr3Bright sorted adult brain cells.
In another study by Hutton and Pevny, the authors have also
found that Sox2 is differentially expressed between neural
progenitors and intermediate progenitor populations (Hutton
and Pevny, 2011). In the study by Obermair et al. (2010), Sox2
expression in CD133, SSEA-1 or ALDH positive cells isolated
from adult mouse brain subventricular zone is lower than that
in themarker-negative cells. And even between CD133 positive
cells, Sox2 expression level dramatically varies depending
on the region where the cells are isolated. This suggests that
high Fabp7 expressing neural stem cells may represent an
1321Neural stem cell isolation from the whole mouse brain using FABP7-binding fluorescent dye, CDr3alternative class of adult neural stem cells that retain neural
stemness while expressing a unique neural stem cell gene
profile.
NSC isolation from the adult mouse brain is more
challenging given the vast amount of white matter and glia
packaging the brain. Most NSC isolation protocols require
additional purification steps prior to NSC sorting such as SVZ
dissection or density centrifugation to remove myelin debris
(Fischer et al., 2011; Brewer and Torricelli, 2007; Capela
and Temple, 2002). In the case of CDr3, we were interested
to show if the compound was specific enough to isolate NSCs
without the need for additional purification steps. When
NSCs were isolated from the whole adult brain using the
different methods and cultured for neurosphere assay, the
largest number of neurospheres was generated from the
cells isolated by CDr3, while no spheres were formed from
CD133 and SSEA-1 antibody sorted cells. Failure of these
antibody-based isolation methods is likely due to lower
expression of these genes in adulthood (Pfenninger et al.,
2007). In the absence of a single defined NSC marker, several
research groups have attempted to classify their observa-
tions into different subpopulations of NSCs based on marker
expression and differentiation potential. Obermair et al.
(2010) reported that only SSEA-1+/ALDH1+ cells are tripotent
among the three main subpopulations of NSCs they identified:
SSEA-1+, ALDH1+ and SSEA-1+/ALDH1+. Interestingly, rapidly
dividing cells in the SVZ were found to be CD133−/SSEA1−/
ALDH1− whereas CD133+ formed a very slowly dividing subtype
of cells. Given our current findings, NSCsmay be best described
as being predominantly FABP7+/SSEA1+/CD133+/ALDH1−, with
a second predominant subset being FABP7+/SSEA-1+/CD133+/
ALDH1+.
The heterogeneity of marker expression in these isolated
cells and its changes over development suggest that a more
comprehensive characterization of these cells is required for
an understanding of their regenerative potential, for which
the inclusion of additional intracellular isolation markers
would be useful.
Conclusion
We have demonstrated that CDr3 can be reliably used as a
marker for the isolation of NSCs from whole embryonic and
adult brain tissues based on specific binding to the intracel-
lular protein, FABP7. This is unique because most existing NSC
isolation methods utilize extracellular markers. The inclusion
of FABP7 as an additional isolationmarkermay shedmore light
on the characteristics of the NSC phenotype, thus paving the
way for more efficient cell isolation techniques and charac-
terization studies.
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